Roots
Analysis has done a detailed
study on Cell and Advanced Therapies Supply
Chain Management Market: Focus on Technological Solutions (Cell Orchestration Platforms,
Enterprise Manufacturing Systems, Inventory Management Systems, Laboratory
Information Management Systems, Logistics Management Systems, Patient
Management Systems, Quality Management Systems, Tracking & Tracing Systems,
and Other Software), 2019-2030,
covering key aspects of the industry’s evolution and identifying potential
future growth opportunities.
To order this 510+
page report, which features 185+ figures and 400+ tables, please visit this -
https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
Key Market Insights
§
Presently, over 160
innovative, software-enabled systems are being used to efficiently manage and
streamline various aspects of the complex supply chain of cell and advanced
therapies
§
Company involved in
this domain are putting in significant efforts to develop advanced software
solutions and also differentiate their offerings, from those of other industry
players, in order to maintain a competitive edge
§
North America is the
major hub of innovation in this field, serving as the base for companies of all
sizes, which are primarily engaged in developing cloud-based solutions for
diverse applications
§
The cell and advanced
therapies market is characterized by an elaborate value chain, involving a
multitude of processes and several stakeholders, each having a discrete set of
priorities and requirements
§
Increase in partnership activity
reflects the growing interest of stakeholders in this industry; over 50% of
reported deals were established to deploy software solutions for enhancing
visibility and supply chain performance
§
An analysis of recent
activity on Twitter reveals the increasing interest and ongoing efforts of
industry stakeholders in providing needle-to-needle traceability and supply
chain orchestration solutions
§
Given their cost saving potential
across different processes and operations, we expect the cell and advanced
therapy supply chain solutions market to grow at an annualized rate of around 25%
over the next decade
§
In the mid-long term,
the projected opportunity is anticipated to be well distributed across various
global regions, different end uses / applications and mode of deployment of
various proprietary software solutions
For more information, please visit https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
